IOVA vs. MATW
IOVA (Iovance Biotherapeutics, Inc.) and MATW (Matthews International Corporation) are both stocks. IOVA operates in Biotechnology (Healthcare), while MATW operates in Conglomerates (Industrials). Over the past 10 years, IOVA returned -7.29%/yr vs -4.79%/yr for MATW. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
IOVA vs. MATW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IOVA achieves a 49.08% return, which is significantly higher than MATW's 8.23% return. Over the past 10 years, IOVA has underperformed MATW with an annualized return of -7.29%, while MATW has yielded a comparatively higher -4.79% annualized return.
IOVA
- 1D
- -13.22%
- 1M
- -5.57%
- 6M
- 59.61%
- YTD
- 49.08%
- 1Y
- 51.87%
- 3Y*
- -17.28%
- 5Y*
- -28.82%
- 10Y*
- -7.29%
- ALL TIME*
- -18.60%
MATW
- 1D
- 0.00%
- 1M
- 3.97%
- 6M
- 7.53%
- YTD
- 8.23%
- 1Y
- 25.31%
- 3Y*
- -12.05%
- 5Y*
- -1.02%
- 10Y*
- -4.79%
- ALL TIME*
- 7.73%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $68.89M | $75.72M | $64.68M | |
| $6.53M | $6.88M | $8.06M |
IOVA vs. MATW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeutics, Inc. | 49.08% | -63.11% | -8.98% | 27.23% | -66.53% | -58.86% | 67.63% | 212.77% | 10.62% | 15.11% |
MATW Matthews International Corporation | 8.23% | -1.50% | -21.25% | 23.36% | -14.50% | 27.72% | -20.49% | -3.95% | -21.88% | -30.53% |
Correlation
The correlation between IOVA and MATW is 0.13, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.13 |
Correlation (3Y) Balances recent behavior with more history. | 0.24 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.23 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.20 |
Correlation (All Time) Calculated using the full available price history since Oct 15, 2010 | 0.17 |
The correlation between IOVA and MATW shifts across timeframes, from 0.13 (1 year) to 0.24 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
IOVA:
$1.82B
MATW:
$865.87M
IOVA:
-$0.89
MATW:
$0.47
IOVA:
5.65
MATW:
0.48
IOVA:
$285.61M
MATW:
$1.21B
IOVA:
$327.04M
MATW:
$432.86M
IOVA:
-$325.45M
MATW:
$201.65M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IOVA vs. MATW — Risk / Return Rank
IOVA
MATW
IOVA vs. MATW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and Matthews International Corporation (MATW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IOVA | MATW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.39 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.14 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 1.50 | 1.45 | +0.05 |
| Martin ratioReturn relative to average drawdown | 2.64 | 3.39 | -0.74 |
Loading charts...
Drawdowns
IOVA vs. MATW - Drawdown Comparison
The maximum IOVA drawdown since its inception was -99.37%, which is greater than MATW's maximum drawdown of -75.27%. Use the drawdown chart below to compare losses from any high point for IOVA and MATW.
Loading charts...
Drawdown Indicators
| IOVA | MATW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -75.27% | -24.10% |
Max Drawdown (1Y)Largest decline over 1 year | -39.00% | -15.87% | -23.13% |
Max Drawdown (3Y)Largest decline over 3 years | -90.50% | -56.86% | -33.64% |
Max Drawdown (5Y)Largest decline over 5 years | -93.99% | -58.68% | -35.31% |
Max Drawdown (10Y)Largest decline over 10 years | -96.84% | -75.27% | -21.57% |
Current DrawdownCurrent decline from peak | -97.44% | -53.19% | -44.25% |
Average DrawdownAverage peak-to-trough decline | -84.27% | -24.85% | -59.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.14% | 6.79% | +15.35% |
Volatility
IOVA vs. MATW - Volatility Comparison
Iovance Biotherapeutics, Inc. (IOVA) has a higher volatility of 30.69% compared to Matthews International Corporation (MATW) at 9.11%. This indicates that IOVA's price experiences larger fluctuations and is considered to be riskier than MATW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IOVA | MATW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.69% | 9.11% | +21.58% |
Volatility (6M)Calculated over the trailing 6-month period | 66.41% | 19.34% | +47.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.87% | 32.22% | +61.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 90.78% | 36.38% | +54.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.92% | 37.02% | +44.90% |
Dividends
IOVA vs. MATW - Dividend Comparison
IOVA has not paid dividends to shareholders, while MATW's dividend yield for the trailing twelve months is around 3.66%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MATW Matthews International Corporation | 3.66% | 3.85% | 4.37% | 2.54% | 2.92% | 2.36% | 2.87% | 2.12% | 1.90% | 1.33% | 0.81% | 1.01% |
Financials
IOVA vs. MATW - Financials Comparison
This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and Matthews International Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IOVA and MATW have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IOVA has higher volatility (30.69%) compared to MATW (9.11%). In terms of maximum drawdown, IOVA dropped -99.37% vs MATW's -75.27%.
MATW currently has the higher Sharpe Ratio (0.71 vs 0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IOVA and MATW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer